Key facts
- NRx Pharmaceuticals announced a proposed public stock offering.
- The offering is subject to market conditions.
- The offering is subject to regulatory approvals.
NRx Pharmaceuticals has announced its intention to conduct a public stock offering. The company stated that the offering is subject to prevailing market conditions and will also require regulatory approvals before it can proceed. Further details regarding the size and terms of the offering were not immediately available.